The physicians' desk reference: Problems and possible improvements

Archives of Internal Medicine

Volumn 156, Issue 13, 1996, Pages 1375-1380

  Cohen, Jay S ^a   Insel, Paul A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INFORMATION; DRUG LABELING; ELDERLY CARE; FOOD AND DRUG ADMINISTRATION; MEDICAL INFORMATION; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

AGED; CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG INFORMATION SERVICES; HUMANS; PRODUCT LABELING; REFERENCE BOOKS, MEDICAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0029885974     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.13.1375     Document Type: Review

References (51)

1. Physicians' Desk Reference. 1st-49th eds. Montvale, NJ: Medical Economics Data Production Co; 1947-1995.
2. Connelly DP, Rich EC, Curley SP, Kelly JT. Knowledge resource preferences of family physicians. J Fam Pract. 1990;30:353-359.
3. American Medical Association. Drug Evaluations, Annual 1993. Chicago, III: American Medical Association; 1993.
4. Greenblatt DJ. Basic pharmacokinetic principles and their application to psychotropic drugs. J Clin Psychiatry. 1993;54(suppl):8-13.
5. Dawling S. Monitoring of tricyclic antidepressant therapy. Clin Biochem. 1982;15:56-61.
6. Woolsey RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA. 1993;269:1532-1536.
7. McEvoy GK, ed. American Hospital Formulary Service, Drug Information 1993. Bethesda, Md: American Society of Hospital Pharmacists; 1994.
8. Brandon ML, Weiner M. Clinical investigation of terfenadine: a non-sedating antihistamine. Ann Allergy. 1980;44:71-75.
9. Brandon ML, Weiner M. Clinical studies of terfenadine (Seldane) in seasonal allergic rhinitis. Arzneimittelforschung. 1982;32:1204-1205.
10. Jick H. Evaluation of drug efficacy by a preference technic. N Engl J Med. 1966;275:1399-1403.
11. Jick H. Comparative studies with a new hypnotic under current investigation. Curr Ther Res. 1967;9:355-357.
12. Merlotti L, Roehrs T, Koshorek G, Zorick F, Lamphere J, Roth T. The dose effects of zolpidem on the sleep of healthy normals. J Clin Psychopharmacol. 1989;9:9-14.
13. Koshorek G, Roehrs T. Sicklesteel J, Merlotti L, Russo L, Roth T. Dose effects of zolpidem on transient insomnia. Sleep Res. 1988;17:47.
14. Vogel G, Thurmond A, Maclntosh M, Clifton T. The effects of zolpidem (Ambien) on transient insomnia. Sleep Res. 1998;17:67.
15. Thompson M, Bell D. Further experience with ibuprofen in the treatment of arthritis. Rheumatol Phys Med. 1970;10(suppl 10):100-103.
16. Chalmers TM. Clinical experience with ibuprofen in the treatment of rheumatoid arthritis. Ann Rheum Dis. 1969;28:513-517.
17. Mutru O, Penttila M, Pesonen J, Salmela P, Suhonen O, Sonck T. Diclofenac sodium (Voltaren) and indomethacin in the ambulatory treatment of rheumatoid arthritis: a double-blind multicentre study. Scand J Rheumatol. 1978;22(suppl): 51-56.
18. Ciccolunghi SN, Chaudri HA, Schubiger Bl, Reddrop R. Report on a long-term tolerability study of up to two years with diclofenac sodium (Voltaren). Scand J Rheumatol. 1978;22(suppl): 86-96.
19. Kantor TG. Use of diclofenac in analgesia. Am J Med. 1986;suppl 4B:64-69.
20. Siegmeth W, Placheta P. Long-term comparative study: diclofenac (Voltaren) and naproxen (Proxen) in arthritis. J Suisse Med. 1978;108: 349-353.
21. Wernicke JF, Dunlop SR, Dornseif BE, Bosomworth JC, Humbert M. Low-dose fluoxetine therapy for depression. Psychopharmacol Bull. 1988;24: 183-188.
22. Altamura AC, Montgomery SA, Wernicke JF. The evidence for 20 mg a day of fluoxetine as the optimal dose in the treatment of depression. Br J Psychiatry. 1988;153(suppl 3):109-112.
23. Langman MJ, Henry DA, Ogilvie A. Ranitidine and cimetidine for duodenal ulcer. Scand J Gastroenterol. 1981;69(suppl):115-117.
24. Dobrilla G. de Pretis G, Felder M, Chilovi F. Endoscopic double-blind controlled trial of ranitidine vs placebo in the short-term treatment of duodenal ulcer. Hepatogastroenterology. 1981; 28:49-52.
25. Berstad A, Kett K, Aadland E, et al. Treatment of duodenal ulcer with ranitidine, a new histamine H2-receptor antagonist. Scand J Gastroenterol. 1980;15:637-639.
26. Lauritsen K, Andersen BN, Havelund T, et al. Effect of 10 mg and 20 mg omeprazole daily on duodenal ulcer: double-blind comparative trial. Aliment Pharmacol Ther. 1989;3:59-67.
27. Kessler DA, Rose JL, Temple RJ, Schapiro R. Griffin JP. Therapeutic-class wars-drug promotion in a competitive marketplace. N Engl J Med. 1994;331:1350-1353.
28. Cain JW. Poor response to fluoxetine: underlying depression, serotonergic overstimulation, or a 'therapeutic window'? J Clin Psychiatry. 1992; 53:272-277.
29. Clark WG, Brater DC, Johnson AR. Goth's Medical Pharmacology. 12th ed. St Louis, Mo: Mosby-Year Book; 1992.
30. Melmon KL, Morrelli HF, Hoffman BB, Nierenberg DW. Melmon and Morrelli's Clinical Pharmacology: Basic Principles in Therapeutics. 3rd ed. New York, NY: McGraw-Hill International Book Co; 1993.
31. Physicians' Desk Reference. 49th ed. Montvale, NJ: Medical Economics Data Production Co; 1995.
32. Beck TM, Ciociola AA, Jones SE, et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamidebased chemotherapy. Ann Intern Med. 1993; 118:407-413.
33. Beck TM. Efficacy of ondansetron tablets in the management of chemotherapy-induced emesis: review of clinical trials. Semin Oncol. 1992;19 (suppl 15):20-25.
34. Cubeddu LX, Pendergrass K, Ryan T, et al. Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Am J Clin Oncol. 1994; 17:137-146.
35. Ob VM. Multiple medication: problems of the elderly patient, Int Dent J. 1991;41:348-358.
36. Brawn LA, Castleden CM. Adverse drug reactions: an overview of special considerations in the management of the elderly patient. Drug Saf. 1990;5:421-435.
37. Recchia AG, Shear NH. Organization and function of an adverse drug reaction clinic. J Clin Psychiatry. 1994;34:68-79.
38. Office of the Inspector General, Health and Human Services. Medical Drug Utilization Review. April 1989.
39. Minotti V, Patoia L, Roila F, et al. Double-blind evaluation of analgesic efficacy of orally administered diclofenac, nefopam, and acetylsalicylic acid (ASA) plus codeine in chronic cancer pain. Pain. 1989;36:177-183.
40. Nuutinen LS, Wuolijoki E, Pentikainen IT. Diclofenac and oxycodone in treatment of postoperative pain: a double-blind trial. Acta Anaesthesiol Scand. 1986;30:620-624.
41. Machtey I. Diclofenac in the treatment of painful joints and traumatic tendinitis (including strains and sprains): a brief review. Semin Arthritis Rheum. 1985;15(suppl 1):87-92.
42. Zuinen C. Diclofenac/misoprostol vs diclofenac/placebo in treating acute episodes of tendinitis/bursitis of the shoulder. Drugs. 1993;45(suppl 1):17-23.
43. Johnson MS. Response of ventricular arrhythmias to propranolol in mitral valve prolapse. Ala Med. 1988;58:14-16.
44. Nierenberg AA, Keck PE Jr. Management of monoamine oxidase inhibitor-associated insomnia with trazodone. J Clin Psychopharmacol. 1989;9:42-45.
45. Nierenberg AA, Adler LA, Peselow E, Zornberg G, Rosenthal M. Trazodone for antidepressant-associated insomnia. Am J Psychiatry. 1994; 151:1069-1072.
46. Metz A, Shader RI. Adverse interactions encountered when using trazodone to treat insomnia associated with fluoxetine. Int Clin Psychopharmacol. 1990;5:191-194.
47. Stern RS. Drug promotion for a unlabeled indication - the case of topical tretinoin. N Engl J Med. 1994;331:1348-1349.
48. Gilman AG, Rall TW, Nies AS, Taylor P. Goodman and Gilman's The Pharmacological Basis of Therapeutics. Elmsford, NY: Pergamon Press Inc; 1990.
49. Jacobsen FM. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry. 1992;53:119-122.
50. Eckman MH, Levine HJ, Pauker SG. Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy. N Engl J Med. 1993;329:696-670.
51. Hull R, Hirsh J, Jay R, et al. Different intensities of anticoagulation in the long-term treatment of proximal venous thrombosis. N Engl J Med. 1982; 307:1676-1681.